Global Ewing Sarcoma Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Ewing Sarcoma - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Ewing Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ewing Sarcoma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Ewing Sarcoma Overview
  3. Therapeutics Development
  4. Pipeline Products for Ewing Sarcoma - Overview
  5. Pipeline Products for Ewing Sarcoma - Comparative Analysis
  6. Ewing Sarcoma - Therapeutics under Development by Companies
  7. Ewing Sarcoma - Therapeutics under Investigation by Universities/Institutes
  8. Ewing Sarcoma Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Ewing Sarcoma - Products under Development by Companies
  13. Ewing Sarcoma - Products under Investigation by Universities/Institutes
  14. Ewing Sarcoma - Companies Involved in Therapeutics Development
  • Astellas Pharma Inc.
  • Cebiotex, S.L.
  • Celgene Corporation
  • EntreChem, S.L.
  • Exelixis, Inc.
  • Gradalis Inc.
  • Ipsen S.A.
  • Kolltan Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Merrimack Pharmaceuticals, Inc.
  • NanoSmart Pharmaceuticals, Inc.
  • Nanovalent Pharmaceuticals Inc.
  • NantKwest, Inc.
  • Novartis AG
  • Oncomatryx Biopharma, S.L.
  • Recombio S.L
  • Shionogi & Co., Ltd.
  • Sigma-Tau S.p.A.
  • Tesaro, Inc.
  • Tokalas, Inc.

For more information visit http://www.researchandmarkets.com/research/g3d7hw/ewing_sarcoma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs